QMS Medical Peer Comparison

NSE: QMSMEDI

₹171.06

₹0.29 (0.17%)

As on 16-Oct-2026IST

Market cap

₹331 Cr

Revenue (TTM)

₹183 Cr

P/E Ratio

30.4

P/B Ratio

Div. Yield

0.3 %

Edit

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Market cap (₹ Cr)	331	16,169	313	207	175
Revenue (₹ Cr)	183	1,997	153	34	94
Net Profit (₹ Cr)	12.72	307.01	4.34	-4.78	2.37
Net Margin (%)	6.90	14.56	2.70	-13.48	2.51
RoE (%)	10.39	10.63	2.29	-30.48	6.25
Price to Earnings	30.38	51.32	72.05	--	73.88
Price-To-Book	--	5.08	1.70	11.82	3.59

Income Statement (₹ Cr)

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Operating Revenue	162.32	1,997.43	153.13	1.42	93.65
Total Income	162.77	2,108.80	160.48	2.24	94.36
Total Expenditure	141.08	1,536.06	148.97	2.04	80.45
EBITDA	21.24	461.36	4.17	-0.61	13.20
Depreciation	4.06	128.17	2.09	0.06	2.26
EBIT	17.18	333.19	2.07	-0.68	10.94
Interest	8.18	21.84	1.24	0.00	4.15
Other Income	0.45	111.37	7.35	0.82	0.71
Exceptional Items	0.00	-6.80	0.00	0.00	0.00
Profit before Tax	9.46	415.92	8.18	0.14	7.50
Provision for Tax	2.78	108.91	3.85	0.00	5.14
Profit after Tax	6.67	307.01	4.34	0.14	2.37

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Shareholder's Funds	104.22	3,106.17	180.76	21.14	46.74
Minority Interest	0.00	2.16	0.00	0.00	0.00
Non-Current Liabilities	24.06	193.80	1.62	0.00	39.30
Current Liabilities	91.76	575.52	13.78	0.68	35.31
Total Liabilities	136.97	1,932.02	205.17	--	41.29

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Non-Current Assets	88.48	1,874.17	14.91	18.54	69.36
Current Assets	130.67	1,941.73	114.68	3.05	50.45
Total Assets	136.97	1,932.02	205.17	--	41.29
Total Debt*	34.55	169.97	0.48	--	25.87
Net Current Assets	38.91	1,366.21	100.90	2.37	15.14
Contingent Liabilities	--	113.16	0.02	--	0.36

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Cash From Operating Activities	1.36	266.08	-2.71	--	4.27
Cash Flow from Investing Activities	-2.78	-240.94	17.58	--	-13.00
Cash from Financing Activities	0.41	-20.15	-1.30	--	8.74
Net Cash Inflow / Outflow	-1.01	4.99	13.56	--	0.02

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
ROCE (%)	14.70	23.63	-1.06	--	19.58
ROE (%)	6.44	10.63	2.29	0.78	6.25
ROA (%)	3.26	8.63	2.14	0.89	2.49
EBIT Margin (%)	10.59	16.68	1.35	-47.47	11.68
Net Margin (%)	4.10	14.56	2.70	6.21	2.51
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Revenue Growth (%)	3.51	18.31	23.92	234.59	42.49
EBIT Growth (%)	-19.51	-9.66	126.08	24.07	34.57
Net Profit Growth (%)	-37.66	-12.67	2,16,900.00	-86.72	-65.86
EPS Growth (%)	-42.45	-10.52	2,18,601.15	-91.46	-71.40
Book Value Growth (%)	11.52	18.34	-0.91	--	44.67

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Price / Earnings	49.57	50.51	74.94	1,288.91	70.93
Price / Book Value	3.09	5.08	1.70	7.26	3.59
Dividend Yield (%)	0.29	0.22	0.00	0.00	0.00
EV/EBITDA	17.09	33.99	65.01	-348.63	15.87
Market Cap (₹ Cr)	208.94	15,247.95	255.15	--	58.94

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Debt to Equity	0.22	0.02	0.00	0.00	0.78
Short term debt to equity ratio	0.40	0.10	0.00	--	1.11
Current Ratio	1.42	3.37	8.32	4.47	1.43
Quick Ratio	0.92	2.62	4.88	4.47	1.01
Interest Coverage	2.16	20.04	7.62	35.75	2.81

	QMS Medical	Poly Medicure	Nureca	Alan Scott	Raaj Medisafe
Debtors to sales (%)	36.45	26.59	5.06	12.73	12.55
Asset Turnover	0.79	0.56	0.75	0.09	0.98
Receivable days	120.20	66.78	10.79	--	62.21
Inventory Days	100.89	56.78	119.26	--	63.61
Payable days	89.36	87.19	30.60	--	9.31
Cash Conversion Cycle	131.72	36.37	99.45	--	116.51

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.